HLA-C and neoplasm: Consistent with the lack of MHC requirement for stimulation of this γδ T cell population, addition of the 20.1 antibody to a panel of human tumor/transformed cell lines, some of which lack MHC surface expression, induced potent activation of responding Vγ9Vδ2 T cells (25).